TY - JOUR
T1 - Sex-based electroclinical differences and prognostic factors in epilepsy with eyelid myoclonia
AU - Cerulli Irelli, Emanuele
AU - Cocchi, Enrico
AU - Ramantani, Georgia
AU - Morano, Alessandra
AU - Riva, Antonella
AU - Caraballo, Roberto H.
AU - Giuliano, Loretta
AU - Yilmaz, Tülay
AU - Panagiotakaki, Eleni
AU - Operto, Francesca F.
AU - Giraldez, Beatriz Gonzalez
AU - Balestrini, Simona
AU - Silvennoinen, Katri
AU - Casciato, Sara
AU - Comajuan, Marion
AU - Fortunato, Francesco
AU - Giallonardo, Anna T.
AU - Gamirova, Rimma
AU - Coppola, Antonietta
AU - Di Gennaro, Giancarlo
AU - Labate, Angelo
AU - Sofia, Vito
AU - Kluger, Gerhard J.
AU - Gambardella, Antonio
AU - Kasteleijn-Nolst Trenite, Dorothee
AU - Baykan, Betul
AU - Sisodiya, Sanjay M.
AU - Arzimanoglou, Alexis
AU - Striano, Pasquale
AU - Di Bonaventura, Carlo
N1 - Publisher Copyright:
© 2023 International League Against Epilepsy.
PY - 2023/6
Y1 - 2023/6
N2 - Although a striking female preponderance has been consistently reported in epilepsy with eyelid myoclonia (EEM), no study has specifically explored the variability of clinical presentation according to sex in this syndrome. Here, we aimed to investigate sex-specific electroclinical differences and prognostic determinants in EEM. Data from 267 EEM patients were retrospectively analyzed by the EEM Study Group, and a dedicated multivariable logistic regression analysis was developed separately for each sex. We found that females with EEM showed a significantly higher rate of persistence of photosensitivity and eye closure sensitivity at the last visit, along with a higher prevalence of migraine with/without aura, whereas males with EEM presented a higher rate of borderline intellectual functioning/intellectual disability. In female patients, multivariable logistic regression analysis revealed age at epilepsy onset, eyelid myoclonia status epilepticus, psychiatric comorbidities, and catamenial seizures as significant predictors of drug resistance. In male patients, a history of febrile seizures was the only predictor of drug resistance. Hence, our study reveals sex-specific differences in terms of both electroclinical features and prognostic factors. Our findings support the importance of a sex-based personalized approach in epilepsy care and research, especially in genetic generalized epilepsies.
AB - Although a striking female preponderance has been consistently reported in epilepsy with eyelid myoclonia (EEM), no study has specifically explored the variability of clinical presentation according to sex in this syndrome. Here, we aimed to investigate sex-specific electroclinical differences and prognostic determinants in EEM. Data from 267 EEM patients were retrospectively analyzed by the EEM Study Group, and a dedicated multivariable logistic regression analysis was developed separately for each sex. We found that females with EEM showed a significantly higher rate of persistence of photosensitivity and eye closure sensitivity at the last visit, along with a higher prevalence of migraine with/without aura, whereas males with EEM presented a higher rate of borderline intellectual functioning/intellectual disability. In female patients, multivariable logistic regression analysis revealed age at epilepsy onset, eyelid myoclonia status epilepticus, psychiatric comorbidities, and catamenial seizures as significant predictors of drug resistance. In male patients, a history of febrile seizures was the only predictor of drug resistance. Hence, our study reveals sex-specific differences in terms of both electroclinical features and prognostic factors. Our findings support the importance of a sex-based personalized approach in epilepsy care and research, especially in genetic generalized epilepsies.
KW - catamenial seizures
KW - drug resistance
KW - genetic generalized epilepsy (GGE)
KW - Jeavons syndrome
KW - photosensitivity
UR - http://www.scopus.com/inward/record.url?scp=85153755637&partnerID=8YFLogxK
U2 - 10.1111/epi.17609
DO - 10.1111/epi.17609
M3 - Article
C2 - 37021337
AN - SCOPUS:85153755637
SN - 0013-9580
VL - 64
SP - e105-e111
JO - Epilepsia
JF - Epilepsia
IS - 6
ER -